The proposed transaction could see Clotamin distributed by several pharmacy and retail chains in the Russian Federation.
PharmaLife is also expected to make safe, timely product registration within the Russian Federation for Clotamin distribution.
Sunpeaks CEO Mackie Barch said: "We look forward to working closely with PharmaLife and our new possible distributors to build market awareness and sales of Clotamin across Russia."